Lifeway Foods, Inc. LWAY
- Market cap
- $331.0M
- P/E
- 30.2×
Follow LWAY
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.68 | 7.20 | 1.81 | 1.84 | 1.43 | 4.51 | 4.55 | 5.26 | 9.93 | 19.50 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 18.48 | 12.09 | 8.66 | 4.75 | 8.89 | 7.20 | 9.00 | 17.33 | 28.61 | 34.20 |
High Price
|
|||
| 320 | 340 | 322 | 307 | 316 | 282 | 291 | 289 | 291 | 295 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 124 | 119 | 103 | 94 | 102 | 119 | 142 | 160 | 187 | 212 |
Revenue
|
|||
| 28.28% | 25.82% | 25.02% | 23.65% | 26.40% | 24.11% | 18.92% | 26.51% | 26.00% | 27.39% |
Gross Margin
|
|||
| 6 | (1) | (3) | 1 | 5 | 6 | 2 | 17 | 14 | 20 |
EBT
|
|||
| 4.55% | (0.68%) | (3.20%) | 1.32% | 4.73% | 4.72% | 1.30% | 10.40% | 7.48% | 9.26% |
EBT Margin
|
|||
| 3 | 0 | (3) | 0 | 3 | 3 | 1 | 11 | 9 | 14 |
Net Income
|
|||
| 3 | 3 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
Depreciation
|
|||
| 7.67 | 7.38 | 6.51 | 5.95 | 6.54 | 7.66 | 9.20 | 10.92 | 12.65 | 13.98 |
Revenue/Sh
|
|||
| 0.22 | (0.02) | (0.19) | 0.03 | 0.21 | 0.21 | 0.06 | 0.77 | 0.61 | 0.91 |
Earnings/Sh
|
|||
| 0.32 | 0.24 | 0.15 | 0.24 | 0.41 | 0.36 | 0.26 | 1.16 | 0.88 | 0.72 |
Cash Flow/Sh
|
|||
| (0.19) | (0.33) | (0.17) | (0.04) | (0.12) | (0.12) | (0.22) | (0.29) | (0.45) | (1.79) |
Capex/Sh
|
|||
| 0.13 | (0.09) | (0.02) | 0.20 | 0.29 | 0.23 | 0.03 | 0.86 | 0.43 | (1.07) |
Free CF/Sh
|
|||
| 2.99 | 2.89 | 2.67 | 2.75 | 3.00 | 3.16 | 3.09 | 4.12 | 4.87 | 5.65 |
Book Value/Sh
|
|||
| 16 | 16 | 16 | 16 | 16 | 16 | 15 | 15 | 15 | 15 |
Shares
|
|||
| 52.09 | 0.00 | 0.00 | 56.21 | 25.76 | 22.45 | 97.23 | 17.17 | 40.00 | 26.63 |
PE Ratio
|
|||
| 1.46 | 1.14 | 0.29 | 0.33 | 0.83 | 0.60 | 0.61 | 1.23 | 1.96 | 1.73 |
PS Ratio
|
|||
| 3.74 | 2.90 | 0.70 | 0.72 | 1.80 | 1.45 | 1.82 | 3.25 | 5.09 | 4.29 |
PB Ratio
|
|||
| 1.44 | 1.12 | 0.32 | 0.33 | 0.78 | 0.58 | 0.63 | 1.16 | 1.88 | 1.72 |
EV/Sales
|
|||
| 87.50 | (89.96) | (108.37) | 9.68 | 17.66 | 19.11 | 164.79 | 14.73 | 56.07 | (22.41) |
EV/FCF
|
|||
| 5 | 4 | 2 | 4 | 6 | 6 | 4 | 17 | 13 | 11 |
Op' Cash Flow
|
|||
| (3) | (5) | (3) | (1) | (2) | (2) | (3) | (4) | (7) | (27) |
Capex
|
|||
| 2 | (1) | 0 | 3 | 4 | 4 | 1 | 13 | 6 | (16) |
FCF
|
|||
| 18 | 11 | 11 | 10 | 16 | 17 | 14 | 22 | 28 | 20 |
Working Cap'
|
|||
| 6 | 3 | 6 | 3 | 3 | 6 | 5 | 1 | — | — |
Total Debt
|
|||
| (3) | (2) | 3 | (1) | (5) | (3) | 1 | (12) | (17) | (6) |
Net Debt
|
|||
| 48 | 47 | 42 | 43 | 47 | 49 | 48 | 60 | 72 | 86 |
Sh' Equity
|
|||
| 5.35% | (0.53%) | (5.09%) | 0.80% | 5.47% | 5.01% | 1.32% | 15.09% | 10.48% | 14.13% |
ROA
|
|||
| 8.30% | (0.74%) | (4.28%) | (2.87%) | 7.38% | 7.96% | 3.03% | 21.80% | 15.69% | 12.60% |
ROIC
|
|||
| 7.43% | (0.73%) | (6.94%) | 1.06% | 7.17% | 6.90% | 1.91% | 21.05% | 13.64% | 17.57% |
ROE
|
|||
Lifeway Foods, Inc. peers in Packaged Foods
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| OTLY Oatly Group AB Sponsored ADR | $387.1M | 0.0× | Compare |
| PRE Prenetics Global Limited | $393.1M | 0.0× | Compare |
| USNA USANA Health Sciences, Inc. | $263.5M | 0.0× | Compare |
| BGS B&G Foods, Inc. | $245.5M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NATR Nature's Sunshine Products, Inc. | $227.2M | 12.7× | Compare |
| BRCC BRC Inc. | $226.3M | 0.0× | Compare |
| HOST Healthy Choice Wellness Corp. | $225.6M | 0.0× | Compare |
| ENHA Enhanced Group Inc. | $593.1M | — | Compare |
Lifeway Foods, Inc. (LWAY) key facts
- Lifeway Foods, Inc. (LWAY) is a Packaged Foods company in the Consumer Defensive sector, listed on Nasdaq.
- Lifeway Foods, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $212.5 million, up 13.7% from fiscal 2024.
- Net income was $13.9 million, or $0.91 per share (basic), a net margin of 6.52%.
- As of September 25, 2026, LWAY traded at $21.74, a market capitalization of $331.0 million.
- At that price the stock trades at 30.2× trailing-twelve-month earnings and 1.4× sales.
- Return on equity was 17.6% and debt-to-equity 0.26.
Lifeway Foods, Inc. (LWAY) Latest News
15 Aug
Lifeway Foods reported record sales for Q2 2026 amid ongoing cost pressures. Record sales signal revenue strength while cost pressures constrain margin gains and limit overall trajectory shift.
13 Aug
Lifeway Foods reports highest quarterly net sales in company history for second quarter 2026, extending its record growth streak. Record net sales growth signals strong momentum that can lift financial results and investor sentiment.
Lifeway Foods Q2 earnings call covered financial results, operational updates and management outlook for the company. Earnings call details typically influence near-term stock sentiment and valuation without guaranteeing long-term structural change.
24 Jul
Lifeway Foods (LWAY) gains from rising consumer health trends. Consumer health trends boost Lifeway Foods performance and market position.
9 Jun
Lifeway Foods, Inc. removes poison pill ahead of shareholders’ meeting. Poison pill removal raises takeover risk and may shift control dynamics ahead of the vote.
8 Jun
Key Lifeway Foods shareholder Edward Smolyansky states termination of the poison pill marks an inflection point for shareholders as governance questions mount ahead of the election. Poison pill termination and governance issues ahead of election signal potential control shifts that can alter company trajectory.
19 May
Danone exits its stake in Lifeway Foods Inc. Danone stake sale changes ownership structure and drives major shifts in Lifeway Foods investor sentiment and stock trajectory.
18 May
Danone will sell its stake in Lifeway Foods. Danone stake sale creates major ownership shift and sharp market reaction for Lifeway.
Danone plans to sell its stake in Lifeway Foods Inc. Danone stake sale triggers major ownership shift with direct effects on Lifeway stock and strategy.
14 May
Lifeway Foods announces record-breaking results for the first quarter ended March 31, 2026. Record-breaking Q1 results indicate transformative financial growth and enhanced long-term prospects for Lifeway Foods.
Lifeway Foods Inc (LWAY) reported record sales in Q1 2026 earnings call, highlighting strategic initiatives amid strong performance. Record sales and strategic initiatives represent major positive developments likely to enhance financial performance and investor sentiment.
Lifeway Foods, Inc. released Q1 2026 earnings call summary detailing financial results, operational updates, and forward guidance. Quarterly earnings call summary reveals financial performance and strategic outlook with moderate influence on market perception.
Lifeway Foods, Inc. (LWAY) announced the pricing of a secondary underwritten public offering of its common stock. Secondary offering increases share float, likely causing moderate short-term price pressure but limited long-term impact.
23 Apr
Lifeway Foods, Inc. (LWAY) partners with Erewhon to launch Tropical Lifeway Smoothie made with organic Lifeway Kefir. Partnership launches new kefir-based smoothie at premium retailer Erewhon, supporting product innovation and visibility with moderate impact.
1 Apr
Lifeway Foods, Inc. (LWAY) projects 32% to 35% growth for first quarter 2026 amid surging momentum. 32% to 35% Q1 growth projection signals major boost to revenue trajectory and investor sentiment.
17 Mar
Lifeway Foods announced strong fourth quarter and record-breaking full year 2025 results, led by its flagship Kefir product. Record-breaking full-year results driven by flagship Kefir represent a game-changing positive shift for LWAY's competitive position and long-term prospects.
Lifeway Foods Inc. (LWAY) reported record sales in Q4 2025 earnings call, highlighting strategic initiatives amid strong performance. Record sales and strategic highlights signal significant boosts to financial trajectory and investor confidence.
Lifeway Foods Q4 earnings call highlights key financial results, strategic updates, and forward guidance for the company. Q4 earnings call highlights detail financial performance and future outlook, significantly impacting investor sentiment and market trajectory.
Lifeway Foods, Inc. (LWAY) released Q4 earnings snapshot reporting key financial results for the quarter. Q4 earnings snapshot reveals financial performance metrics that significantly affect stock valuation and future market trajectory.
27 Feb
Lifeway Foods celebrates 40 years of kefir leadership by unveiling new cultured dairy innovations at Expo West 2026. New product innovations at a major trade expo signal moderate advancements in competitive positioning and potential sales growth.
5 Feb
Lifeway Foods, Inc. launched a social media campaign featuring Colston Loveland and D'Andre Swift to promote its kefir products during the Big Game weekend. The campaign aims to engage consumers through social-first strategies, leveraging the popularity of the event and the influencers involved to boost brand visibility and sales. The campaign is expected to moderately influence brand awareness and sales, but its overall impact on the company's long-term trajectory remains limited.
2 Feb
Lifeway Foods, Inc. (LWAY) faces significant challenges that could impact its future performance. The company has struggled with declining sales and increased competition in the probiotic market. Analysts express concerns over its ability to innovate and adapt to changing consumer preferences. Additionally, financial metrics indicate potential liquidity issues, raising questions about its long-term viability. The overall market sentiment towards LWAY remains cautious as investors weigh these factors against the company's strategic initiatives. Declining sales and increased competition could significantly alter the company's trajectory and investor sentiment.
30 Jan
Lifeway Foods, Inc. has introduced a new Power Play Shake, enriched with kefir, to support Barry's 'Find Your Strength' challenge. This shake aims to provide a nutritious option for participants looking to enhance their fitness journey. The collaboration highlights Lifeway's commitment to promoting health and wellness through innovative products. The launch of a new product targeting fitness enthusiasts may positively influence brand perception and sales, but its overall impact on the company's trajectory is expected to be limited.
13 Jan
Lifeway Foods, Inc. has launched Probiotic Kefir Butter™, a premium European-style cultured butter that combines the health benefits of probiotics with the rich flavor of traditional butter. This new product is designed to cater to health-conscious consumers seeking high-quality dairy options. The introduction of Probiotic Kefir Butter™ aligns with Lifeway's commitment to innovation in the dairy sector and expands its product line in the cultured dairy market. The launch of a new premium product is likely to significantly impact Lifeway's market positioning and consumer interest.
8 Jan
Lifeway Foods, Inc. anticipates record-breaking results for 2025, driven by strong demand for its kefir products. The company also announced its participation in the upcoming ICR Conference, highlighting its commitment to growth and innovation in the health food sector. Record-breaking expectations and participation in a significant conference indicate major strategic moves that could enhance market positioning.
7 Jan
Lifeway Foods, Inc. commends the new federal dietary guidelines that emphasize the importance of protein, full-fat dairy, and fermented foods such as kefir. The company views these guidelines as aligning with its product offerings and promoting health benefits associated with its dairy products. The new dietary guidelines could significantly boost demand for Lifeway's kefir and dairy products, impacting market performance positively.
31 Dec
Lifeway Foods, Inc. (LWAY) is highlighted as one of three growth companies favored by insiders, indicating potential for significant future performance. The company is noted for its innovative product offerings in the health and wellness sector, which align with current consumer trends. Insider buying activity suggests confidence in the company's strategic direction and growth prospects. Investors may find Lifeway Foods an attractive option as it continues to expand its market presence and capitalize on the increasing demand for probiotic and functional foods. Insider buying activity and innovative product offerings suggest significant confidence in the company's growth trajectory.
19 Dec
Edward Smolyansky, CEO of Lifeway Foods, Inc., responded to the ISS board recommendation regarding the company's governance and strategic direction. He emphasized the importance of shareholder engagement and outlined the company's commitment to enhancing value through innovation and operational efficiency. Smolyansky's remarks reflect a proactive approach to addressing investor concerns and positioning Lifeway for future growth amidst competitive market dynamics. The response to ISS indicates a focus on governance and shareholder engagement, which may moderately influence investor sentiment and operational strategies.
18 Dec
Lifeway Foods, Inc. has received a recommendation from Institutional Shareholder Services (ISS) supporting its nominees for the board of directors. This endorsement is significant as it may influence shareholder voting and bolster the company's governance structure. The recommendation comes amid ongoing efforts by Lifeway to enhance its strategic direction and operational performance. The ISS recommendation could moderately influence shareholder sentiment and governance, impacting the company's strategic direction.
15 Dec
Edward Smolyansky, a shareholder of Lifeway Foods, Inc. (LWAY), has released key deposition insights urging investors to withhold votes for legacy directors Dorri McWhorter, Julie Smolyansky, and Jason Scher. His call for action highlights concerns regarding the company's governance and leadership, potentially impacting shareholder confidence and future decision-making. Concerns raised about governance and leadership could significantly influence investor sentiment and the company's strategic direction.